Lisata Therapeutics Inc (LSTA)

[Viperciara]

You may be asking the wrong person LOL But my answer is that financing I really do not think is a problem right now or for the coming year. I have believed in the science of NBS is as solid as it gets! I have been in this stock a little over 2 years now. I believe the valuation should have been in the high $6 a share range before this news but it has been plagued by shorts for at least the last year. In my opinion the market makers for some reason walk the PPS on this stock down everyday, if you go to http://www.nasdaq.com/symbol/nbs/after-hours it is afterhours now but I watch them walk it down 50 to 100 shares at a time. I do not think they can hold it down now! People have to realize this is the biggest grant ever awarded to a private company. To put $17-$18 million into something means a lot of people really believe they will succeed. They also have PCT which brings in money. I have seen analyst say NBS should be from $6 all the way to $20 a share by years end. At the price it is now it in my mind should be around the $8 to $12 dollar range by years end. If NBS (there trails are looking good)can cure a stage IV metastatic melanoma we will be over $50 a share easily in a few years. The science for this can be used on other cancers in the future. I believe the stock will also go up because now we are a target for a buyout IMHO! The big pharms have been slowly buying out small Bio's. They usually wait to they have a positive phase 2 or 3 trails then jump in! Stem Cells are the future of medicine and we have come to a point where they now understand how to use them to cure patients and that is why this stock is so valuable! NBS has the science that is working!